Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Koopmeiners

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Clinical Trials (London, England)|October 2, 2013
A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomesJoseph S Koopmeiners, Jaime Modiano
BMC Medical Research Methodology|April 16, 2014
Evaluating the performance of copula models in phase I-II clinical trials under model misspecificationKristen Cunanan, Joseph S Koopmeiners
Statistics in Medicine|November 6, 2015
Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalenceJoseph S Koopmeiners, Ziding Feng
Annals of Statistics|September 17, 2013
Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control SamplingJoseph S Koopmeiners, Ziding Feng
Journal of Biopharmaceutical Statistics|March 25, 2017
The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRMJoseph S Koopmeiners, Andrew Wey
Statistical Methods in Medical Research|May 9, 2017
Hierarchical models for sharing information across populations in phase I dose-escalation studiesKristen M Cunanan, Joseph S Koopmeiners
Statistical Methods in Medical Research|September 3, 2016
Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trialsJoseph S Koopmeiners, Brian P Hobbs
Statistics in Medicine|August 23, 2016
A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccinesKristen M Cunanan, Joseph S Koopmeiners
Statistics in Medicine|January 22, 2020
A fully Bayesian mixture model approach for identifying noncompliance in a regulatory tobacco clinical trialAlexander M Kaizer, Joseph S Koopmeiners
Statistics in Medicine|February 16, 2013
Early termination of a two-stage study to develop and validate a panel of biomarkersJoseph S Koopmeiners, Rachel Isaksson Vogel
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Clinical Trials (London, England)|October 2, 2013
A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomesJoseph S Koopmeiners, Jaime Modiano
BMC Medical Research Methodology|April 16, 2014
Evaluating the performance of copula models in phase I-II clinical trials under model misspecificationKristen Cunanan, Joseph S Koopmeiners
Statistics in Medicine|November 6, 2015
Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalenceJoseph S Koopmeiners, Ziding Feng
Annals of Statistics|September 17, 2013
Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control SamplingJoseph S Koopmeiners, Ziding Feng
Journal of Biopharmaceutical Statistics|March 25, 2017
The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRMJoseph S Koopmeiners, Andrew Wey
Statistical Methods in Medical Research|May 9, 2017
Hierarchical models for sharing information across populations in phase I dose-escalation studiesKristen M Cunanan, Joseph S Koopmeiners
Statistical Methods in Medical Research|September 3, 2016
Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trialsJoseph S Koopmeiners, Brian P Hobbs
Statistics in Medicine|August 23, 2016
A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccinesKristen M Cunanan, Joseph S Koopmeiners
Statistics in Medicine|January 22, 2020
A fully Bayesian mixture model approach for identifying noncompliance in a regulatory tobacco clinical trialAlexander M Kaizer, Joseph S Koopmeiners
Statistics in Medicine|February 16, 2013
Early termination of a two-stage study to develop and validate a panel of biomarkersJoseph S Koopmeiners, Rachel Isaksson Vogel
Pageof 13